- Home
- LIDR vs BCLI Comparison
LIDR vs BCLI Comparison
Compare LIDR & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIDR
- BCLI
- Stock Information
- Founded
- LIDR 2013
- BCLI 2000
- Country
- LIDR United States
- BCLI United States
- Employees
- LIDR N/A
- BCLI N/A
- Industry
- LIDR Auto Parts:O.E.M.
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LIDR Consumer Discretionary
- BCLI Health Care
- Exchange
- LIDR Nasdaq
- BCLI Nasdaq
- Market Cap
- LIDR 9.8M
- BCLI 7.7M
- IPO Year
- LIDR N/A
- BCLI N/A
- Fundamental
- Price
- LIDR $0.71
- BCLI $1.12
- Analyst Decision
- LIDR Hold
- BCLI Strong Buy
- Analyst Count
- LIDR 1
- BCLI 1
- Target Price
- LIDR N/A
- BCLI $30.00
- AVG Volume (30 Days)
- LIDR 1.2M
- BCLI 3.4M
- Earning Date
- LIDR 05-08-2025
- BCLI 05-15-2025
- Dividend Yield
- LIDR N/A
- BCLI N/A
- EPS Growth
- LIDR N/A
- BCLI N/A
- EPS
- LIDR N/A
- BCLI N/A
- Revenue
- LIDR $246,000.00
- BCLI N/A
- Revenue This Year
- LIDR $2,677.23
- BCLI N/A
- Revenue Next Year
- LIDR $409.09
- BCLI N/A
- P/E Ratio
- LIDR N/A
- BCLI N/A
- Revenue Growth
- LIDR N/A
- BCLI N/A
- 52 Week Low
- LIDR $0.49
- BCLI $0.72
- 52 Week High
- LIDR $4.30
- BCLI $8.25
- Technical
- Relative Strength Index (RSI)
- LIDR 50.26
- BCLI 47.37
- Support Level
- LIDR $0.71
- BCLI $1.00
- Resistance Level
- LIDR $0.84
- BCLI $1.92
- Average True Range (ATR)
- LIDR 0.06
- BCLI 0.17
- MACD
- LIDR 0.00
- BCLI -0.01
- Stochastic Oscillator
- LIDR 49.61
- BCLI 13.04
About LIDR AEye Inc.
AEye Inc is a provider of high-performance, active lidar systems for vehicle autonomy, driver-assistance systems (ADAS), and robotic vision applications. The company's software-definable 4Sight Intelligent Sensing Platform combines solid-state active lidar, an optionally fused low-light HD camera, and integrated deterministic artificial intelligence to capture more intelligent information with less data, enabling faster, more accurate, and more reliable perception of the surroundings. Majority of the Company's revenue is generated from customers located in the United States followed by Europe, and Asia-Pacific.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.